Cytokine inhibitors in COVID-19: looking back to move forward

Tamas Szakmany^{1

2}, Natalie Duric³

Affiliations

¹ Critical Care Directorate, Grange University Hospital, Aneurin Bevan University Health Board, Cwmbran, UK - szakmanyt1@cardiff.ac.uk.
² Division of Population Medicine, Department of Anaesthesia, Intensive Care and Pain Medicine, Cardiff University, Cardiff, UK - szakmanyt1@cardiff.ac.uk.
³ Critical Care Directorate, Grange University Hospital, Aneurin Bevan University Health Board, Cwmbran, UK.

Free article

Comment

Tamas Szakmany et al. Minerva Anestesiol. 2021 Aug.

Free article

. 2021 Aug;87(8):848-850.

doi: 10.23736/S0375-9393.21.15837-7.

Tamas Szakmany^{1

2}, Natalie Duric³

¹ Critical Care Directorate, Grange University Hospital, Aneurin Bevan University Health Board, Cwmbran, UK - szakmanyt1@cardiff.ac.uk.
² Division of Population Medicine, Department of Anaesthesia, Intensive Care and Pain Medicine, Cardiff University, Cardiff, UK - szakmanyt1@cardiff.ac.uk.
³ Critical Care Directorate, Grange University Hospital, Aneurin Bevan University Health Board, Cwmbran, UK.

No abstract available

Comment on

Immunosuppressive strategies in invasively ventilated ARDS COVID-19 patients.
Monti G, Campochiaro C, Zangrillo A, Scandroglio AM, Fominskiy E, Cavalli G, Landoni G, Beretta L, Mucci M, Calabrò MG, Pieri M, Nardelli P, Sartorelli M, Baiardo Redaelli M, Morselli F, Serpa Neto A, Bellomo R, Dagna L; COVID-BioB Study Group. Monti G, et al. Minerva Anestesiol. 2021 Aug;87(8):891-902. doi: 10.23736/S0375-9393.21.15339-8. Epub 2021 Jun 8. Minerva Anestesiol. 2021. PMID: 34102804